Mythic Therapeutics
Biotechnology company that discovered a key mechanism governing how antibody drugs interact with target cells, using this understanding to significantly improve upon existing FDA-approved antibody therapies.
Website
https://www.mythictx.comLocation
Waltham, Massachusetts, USA
Founded
2020
Investors
1
Categories
antibody-therapy, therapeutics, oncology, biotech, drug-discovery
Notes
Mythic Therapeutics is a biotechnology company that has uncovered fundamental mechanisms governing how antibody drugs interact with target cells. The company is leveraging these discoveries to develop enhanced versions of existing FDA-approved antibody therapies with improved efficacy and safety profiles.
Mythic's approach enables the creation of next-generation antibody therapeutics that can overcome limitations of current treatments, potentially providing better outcomes for patients with cancer and other serious diseases.
Team
- Information on leadership team pending further research
Additional Research Findings
- Founded around 2020
- Headquarters in Waltham, Massachusetts
- Novel antibody-cell interaction discoveries
- Improving existing FDA-approved antibody drugs
- Focus on oncology applications
- Platform-based approach to drug development
- Part of Boston/Cambridge biotech hub
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |